Meirong Huo

China Pharmaceutical University — China

Materials Science · Physical Sciences

31h-index6.9kcitations63works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoparticle-Based Drug Delivery(38), Nanoplatforms for cancer theranostics(25), Advanced Drug Delivery Systems(10), RNA Interference and Gene Delivery(9), Immunotherapy and Immune Responses(8)

Publications63 total

Self-reinforcing nano-spearhead drives the efficacy of CAR-T cells against progressive triple negative breast cancer
Materials Today·2024· 5 cited
Bioresponsive nanocomplex integrating cancer-associated fibroblast deactivation and immunogenic chemotherapy for rebuilding immune-excluded tumors
Nanomedicine Nanotechnology Biology and Medicine·2024· 6 cited
Red blood membrane camouflaging Bismuth nanoflowers designed for radio-photothermal therapy in lung cancer
Journal of drug targeting·2024· 3 cited
Sensitization Strategies of Lateral Flow Immunochromatography for Gold Modified Nanomaterials in Biosensor Development
International Journal of Nanomedicine·2023· 16 citedOpen Access
Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem
Journal of Controlled Release·2023· 20 cited
Synergistic strategy based on mild phototherapy and deep tumor hypoxia reversal comprehensively remodels the tumor microenvironment for improved immunotherapy
Chemical Engineering Journal·2023· 12 cited
Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment
Biomaterials·2023· 59 cited
Dextran 40 hybrid biomimetic bismuth-nanoflower designed for NIR II-triggered hypoxic tumor thermoradiotherapy via macrophage escape
Carbohydrate Polymers·2023· 11 cited
A biocompatible nano-barium sulfonate system for quad-modal imaging-guided photothermal radiotherapy of tumors
Biomaterials Science·2023· 9 cited
A pHe sensitive nanodrug for collaborative penetration and inhibition of metastatic tumors
Journal of Controlled Release·2022· 21 cited
The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment
Biomaterials·2022· 67 cited
Dual Targeting of Cancer Cells and MMPs with Self-Assembly Hybrid Nanoparticles for Combination Therapy in Combating Cancer
Pharmaceutics·2021· 18 citedOpen Access
Redox-sensitive hyaluronic acid-cholesterol nanovehicles potentiate efficient transmembrane internalization and controlled release for penetrated “full-line” inhibition of pre-metastatic initiation
Journal of Controlled Release·2021· 23 cited
Hypoxia-Sensitive Zwitterionic Vehicle for Tumor-Specific Drug Delivery through Antifouling-Based Stable Biotransport Alongside PDT-Sensitized Controlled Release
Biomacromolecules·2021· 15 cited
Biomineralization-inspired dasatinib nanodrug with sequential infiltration for effective solid tumor treatment
Biomaterials·2020· 27 cited
Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma
UNC Libraries·2020· 3 citedOpen Access
Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment
UNC Libraries·2020· 7 citedOpen Access
Novel Chitosan Derivatives with Reversible Cationization and Hydrophobicization for Tumor Cytoplasm-Specific Burst Co-delivery of siRNA and Chemotherapeutics
ACS Applied Materials & Interfaces·2020· 34 cited
Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumor treatment through chemotherapy sensitization and microenvironment modulation
Journal of Controlled Release·2020· 113 cited
Remodeling the fibrotic tumor microenvironment of desmoplastic melanoma to facilitate vaccine immunotherapy
Nanoscale·2020· 31 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Jianping Zhou(30), Tingjie Yin(22), Lifang Yin(12), Jiyong Liu(10), Aifeng Zou(6), Honglan Wang(5), Han Cai(5), Jing Li(4), Jing Wang(4), Qinnv Zhu(4), Qiang Zhang(4), Lihui Dong(4), Lingchao Li(4), Xuxin Chu(4), Ying Fu(4), Lei Wang(4), Jianping Zhou(3), Chengli Yao(3), Yanyu Xiao(3), Yong Zhang(3)